ARWR
Arrowhead Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ARWR Filings
Filing Date
Form Description
Form Type
2025-12-01
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-01 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-28
Form 144 - Report of proposed sale of securities
Ownership
2025-11-28 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-25
Arrowhead Pharmaceuticals, Inc. (ARWR) Q4 2025 Earnings Call Transcript
Earnings Call
2025-11-25 · Earnings Call
Arrowhead Pharmaceuticals, Inc. (ARWR) Q4 2025 Earnings Call Transcript
2025-11-25
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2025-11-25 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025-11-25
Form 8-K - Current report
Key Events
2025-11-25 · Key Events
Form 8-K - Current report
2025-11-18
Form 8-K - Current report
Key Events
2025-11-18 · Key Events
Form 8-K - Current report
2025-10-10
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Financials
2025-10-10 · Financials
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025-10-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-01
Form 144 - Report of proposed sale of securities
Ownership
2025-10-01 · Ownership
Form 144 - Report of proposed sale of securities
2025-09-16
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-09-16 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
